Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 139
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #233: FDA Floats Ibogaine Trial Design; Compass Talks Pricing; Potential LSD, Psilocybin Brand Names
Kenneth Tupper, PhD: Harm Reduction, Drug Education, Canadian Ayahuasca, and Psychedelic Public Health
Weekly Psychedelic Policy Briefing: October 5, 2026
Podcast: Oregon Backtracks on Fee Hike, California Funds Psychedelic Research, DEA Moves to Schedule 5 Tryptamines
Psychedelic Churches Need Psychedelic Seminaries
FDA Grants Ehave Consent to Proceed With Its Clinical Study on...
Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical...
Kabir Nath: Our Mission, Progress and Future Perspectives
Israeli Biotech Clearmind Medicine Announces Positive Pre-Clinical Results Treating Major Depression...
PT385 – Relationships, Conviviality, and The Strength of Empathic Attunement
Kabir Nath: our mission, progress and future perspectives
Late-Stage Psychedelic Trials: A brief review of the two most mature...
Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum...
Doing Things Differently: Beyond Business as Usual in the Psychedelics Space
Adelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining...
Load more